Prospect of Doripenem in Bangladesh Pharma Market

Hossain, Shahriar

dc.contributor.author	Hossain, Shahriar
dc.date.accessioned	2019-02-26T09:47:47Z
dc.date.available	2019-02-26T09:47:47Z
dc.date.issued	12/23/2009
dc.identifier.uri	http://dspace.ewubd.edu/handle/2525/2983
dc.description	This thesis submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy (B.Pharm) in East West University, Dhaka, Bangladesh.	en_US
dc.description.abstract	Doripenem is a novel carbapenem drug. It is broad spectrum antibiotic. Effort was given to find about the characteristics of the drug and whether it is suitable to launch in the Bangladesh market. Information was gathered from website, journal and books. For market fisibility study IMS, MIMS and QUIMP was observed. It was found that doripenem is non inferior to meropenem, imipenem and ertapenem. It can be used in the complicated urinary tract infections and complicated intra abdominal infections. Doripenem is not in Bangladesh yet. If it is launched doripenem market size would be 10,00,000 taka and its growth would be 10% first year, 25% second year, 15% in third year. From the information from market fisibilty study, swot analysis and product positioning it may be profitable to launch doripenem in Bangladesh.	en_US
dc.language.iso	en_US	en_US
dc.publisher	East West University	en_US
dc.relation.ispartofseries	;PHA00049
dc.subject	Doripenem in Bangladesh Pharma Market	en_US
dc.title	Prospect of Doripenem in Bangladesh Pharma Market	en_US
dc.type	Thesis	en_US